Optical phase conjugation (OPC) has emerged as a powerful technique to counteract the deleterious effects of nonlinearity and dispersion in fibre communication systems. By generating a phase-inverted ...
Preliminary data presented at the AACR-NCI-EORTC conference will provide insights into the potential of ZW191 in patients ...
SHANGHAI, July 8, 2025 /PRNewswire/ -- Duality Biotherapeutics' ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing ...
Squibb announced the oral presentation of the first disclosure of the safety and efficacy data from the global ...
AstraZeneca (NASDAQ:AZN) and partner Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) on Saturday announced data from two ...
A phase I first-in-human clinical trial with PLZ4-coated paclitaxel-loaded micelles (PPM) in therapy-resistant non-muscle-invasive bladder cancer (NMIBC). This is an ASCO Meeting Abstract from the ...
Data from the Phase 1 trial of ZW191 provide readthrough to Zymeworks’ broader ADC portfolio utilizing its novel bystander active topoisomerase-1 inhibitor payload, ZD06519.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback